Composition for inhibiting anti-cancer drug resistance
AssigneeAjou University Industry-Academic Cooperation Foundation
InventorsHoon HUR, In-Hye Ham
Life of this patent
Estimating the term…
Abstract
Provided is a composition for inhibiting anti-cancer drug resistance comprising a compound represented by Chemical Formula 1 below as an active ingredient: (wherein, R1 and R2 are each independently hydrogen, substitutable linear or branched C1-C12 alkyl, substitutable C3-C12 cycloalkyl, or substitutable C6-C18 aryl, R3 is carboxyl, hydroxyl, or acetyl, and the substitution is performed by oxygen, nitrogen, sulfur, linear or branched C1-C6 alkyl, C6-C20 aryl, halogen, or a combination thereof).
Claims10
A composition for inhibiting anti-cancer drug resistance comprising a compound represented by Chemical Formula 1 below as an active ingredient:
- (wherein,
- R1 and R2 are each independently hydrogen, substitutable linear or branched C1-C12 alkyl, substitutable C3-C12 cycloalkyl, or substitutable C6-C18 aryl,
- R3 is carboxyl, hydroxyl, or acetyl, and
- the substitution is performed by oxygen, nitrogen, sulfur, linear or branched C1-C6 alkyl, C6-C20 aryl, halogen, or a combination thereof).
Dependencies are inferred from the claim text.